Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Gilliot O, Durando X, Abrial C, Bellière A, Gimbergues P, Thivat E, Planchat E, Lapeyre M, Kwiatkowski F, Toledano I, Chollet P, Nabholtz JM, Verrelle P. Gilliot O, et al. Among authors: nabholtz jm. Cancer Invest. 2010 Feb;28(2):195-200. doi: 10.3109/07357900903179658. Cancer Invest. 2010. PMID: 19968496
Prognostic value of initial tumor parameters after metastatic relapse.
Planchat E, Durando X, Abrial C, Thivat E, Mouret-Reynier MA, Ferrière JP, Pomel C, Kwiatkowski F, Chollet P, Nabholtz JM. Planchat E, et al. Among authors: nabholtz jm. Cancer Invest. 2011 Nov;29(9):635-43. doi: 10.3109/07357907.2011.621911. Cancer Invest. 2011. PMID: 22011286
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.
Nabholtz JM, Chalabi N, Radosevic-Robin N, Dauplat MM, Mouret-Reynier MA, Van Praagh I, Servent V, Jacquin JP, Benmammar KE, Kullab S, Bahadoor MR, Kwiatkowski F, Cayre A, Abrial C, Durando X, Bignon YJ, Chollet P, Penault-Llorca F. Nabholtz JM, et al. Int J Cancer. 2016 May 1;138(9):2274-80. doi: 10.1002/ijc.29952. Epub 2015 Dec 28. Int J Cancer. 2016. PMID: 26649807 Clinical Trial.
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P, Penault-Llorca F, Nabholtz JM. Wang-Lopez Q, et al. Among authors: nabholtz jm. Crit Rev Oncol Hematol. 2015 Jul;95(1):88-104. doi: 10.1016/j.critrevonc.2015.02.011. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25900915 Review.
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
Monrigal E, Dauplat J, Gimbergues P, Le Bouedec G, Peyronie M, Achard JL, Chollet P, Mouret-Reynier MA, Nabholtz JM, Pomel C. Monrigal E, et al. Among authors: nabholtz jm. Eur J Surg Oncol. 2011 Oct;37(10):864-70. doi: 10.1016/j.ejso.2011.07.009. Epub 2011 Aug 16. Eur J Surg Oncol. 2011. PMID: 21843920
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.
Nabholtz JM, Abrial C, Mouret-Reynier MA, Dauplat MM, Weber B, Gligorov J, Forest AM, Tredan O, Vanlemmens L, Petit T, Guiu S, Van Praagh I, Jouannaud C, Dubray-Longeras P, Tubiana-Mathieu N, Benmammar KE, Kullab S, Bahadoor MR, Radosevic-Robin N, Kwiatkowski F, Desrichard A, Cayre A, Uhrhammer N, Chalabi N, Chollet P, Penault-Llorca F. Nabholtz JM, et al. Ann Oncol. 2014 Aug;25(8):1570-7. doi: 10.1093/annonc/mdu183. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827135 Free article. Clinical Trial.
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies.
Radosevic-Robin N, Selenica P, Zhu Y, Won HH, Berger MF, Ferrando L, Cocco E, Privat M, Ponelle-Chachuat F, Abrial C, Nabholtz JM, Penault-Llorca F, Reis-Filho JS, Scaltriti M. Radosevic-Robin N, et al. Among authors: nabholtz jm. NPJ Breast Cancer. 2021 Sep 17;7(1):124. doi: 10.1038/s41523-021-00334-5. NPJ Breast Cancer. 2021. PMID: 34535679 Free PMC article.
112 results